Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 6/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4498396 | 0.94 | NR1I2 (0.45) | NR1I2KCNH2CYP3A4SCN5ACYP2C9 | |
| SCHEMBL19316490 | 0.92 | NR1I2 (0.45) | NR1I2KCNH2CYP3A4SCN5ACYP2C9 | |
| SCHEMBL3365767 | 0.91 | NR1I2 (0.46) | NR1I2KCNH2CYP3A4SCN5ACYP2C9 | |
| SCHEMBL841197 | 0.89 | NR1I2 (0.44) | NR1I2KCNH2CYP3A4SCN5ACYP2C9 | |
| SCHEMBL51368 | 0.88 | NR1I2 (0.42) | NR1I2KCNH2CYP3A4SCN5ACYP2C9 | |
| SCHEMBL50267 | 0.88 | NR1I2 (0.52) | NR1I2KCNH2CYP3A4SCN5ACYP2C9 | |
| SCHEMBL50717 | 0.88 | NR1I2 (0.46) | NR1I2KCNH2CYP3A4SCN5ACYP2C9 | |
| SCHEMBL13531015 | 0.88 | NR1I2 (0.43) | NR1I2KCNH2CYP3A4SCN5ACYP2C9 | |
| SCHEMBL18661372 | 0.87 | NR1I2 (0.47) | NR1I2KCNH2CYP3A4SCN5ACYP2C9 | |
| SCHEMBL18661388 | 0.87 | NR1I2 (0.49) | NR1I2KCNH2CYP3A4SCN5ACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2310396-B1 | MACROCYCLIC INDOLE DERIVATIVES USEFUL AS HEPATITIS C VIRUS INHIBITORS | JANSSEN SCIENCES IRELAND UC (IE) | 2017-09-06 | — | — | EP | disclosed |
| EP-2401280-B1 | Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2013-05-01 | — | — | EP | disclosed |